Aoxiang Pharmaceuticals: has repurchased a total of 5,201,200 shares, with a total amount of 50,006,000 yuan.

Aoxiang Pharmaceutical announced that on January 24, 2025, the company passed a resolution to repurchase shares using 50-100 million yuan of its own or raised funds, for the purpose of equity incentive and/or employee shareholding plan. The repurchase period is until January 23, 2026. Due to the annual equity distribution in 2024, the maximum repurchase price was adjusted to not exceed 13.90 yuan per share starting from July 17, 2025. As of October 31, 2025, the company has repurchased a total of 5.2012 million shares, accounting for 0.63% of the total share capital, for a total amount of 50.06 million yuan, at a transaction price ranging from 7.52 yuan per share to 11.39 yuan per share. There was no repurchase in October.